AMRS - アミリス (Amyris Inc.) アミリス

 AMRSのチャート


 AMRSの企業情報

symbol AMRS
会社名 Amyris Inc (アミリス)
分野(sector) Basic Industries   素材
産業(industry) Major Chemicals  
業種 化学_特殊化学製品   エネルギ―(Energy)
概要 事業概要 アミリス(Amyris Inc.)は統合産業バイオテクノロジー企業である。同社は燃料及びファルネセン製品の研究開発及び販売に従事する。同社は化粧品、フレーバーおよび香料(F&F)、溶剤およびクリーナー、ポリマー、潤滑剤、ヘルスケア製品および燃料を含む消費者および産業市場に製品をエンジニアリング、製造および販売し、工業用合成生物学プラットフォームを適用する。同社はファルネセン(Biofene)と呼ばれる再生可能炭化水素分子に焦点を当てる。同社は消費者向けアプリケーションと産業用アプリケーション向け製品を提供する。同社は消費者向けアプリケーションでは、化粧品とF&Fの原料を含むパーソナルケア製品、「Biossance」というブランドのスキンケア製品、「Muck Daddy」というブランドのハンドクリーナー製品などのヘルスケア製品と最終製品を開発、販売する。   アミリスは米国の化学品会社。合成生物学的手法を用いた再生可能化学品を製造、販売。「バイオフェネ」のブランド名で再生可能ファルネセン(液体炭化水素分子)を化粧品、医薬品、香味・香料、燃料製品の市場をタ―ゲットに販売。また、ブラジルで再生可能ディ―ゼル燃料とジェット燃料を製造、販売。本社はカリフォルニア州。   Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.
本社所在地 5885 Hollis Street Suite 100 Emeryville CA 94608 USA
代表者氏名 John G. Melo ジョン・G・メロ
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 510-450-0761
設立年月日 37803
市場名 NASDAQ National Market System
ipoyear 2010年
従業員数 440人
url www.amyris.com
nasdaq_url https://www.nasdaq.com/symbol/amrs
adr_tso
EBITDA EBITDA(百万ドル) -19.56500
終値(lastsale) 8.63
時価総額(marketcap) 434812703.17
時価総額 時価総額(百万ドル) 463.39030
売上高 売上高(百万ドル) 150.97700
企業価値(EV) 企業価値(EV)(百万ドル) 620.61230
当期純利益 当期純利益(百万ドル) -98.79000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Amyris Inc revenues increased 19% to $46.2M. Net loss applicable to common stockholders increased 91% to $90.8M. Revenues reflect Europe segment increase from $9.1M to $31.6M South America segment increase from $80K to $930K. Higher net loss reflects FV/Uls Adjust on Derivatives for Hedging decrease from $38.1M (income) to $39.5M (expense) Sales.

 AMRSのテクニカル分析


 AMRSのニュース

   The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors  2020/10/08 13:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $AMRS #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Amyris, Inc (“Amyris” or the “Company”) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On March 19, 2019, Amyris announced was unable to file its annual report for fiscal year ended December 31, 2018 on time due to “the significant time and resources that were devoted to
   Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed  2020/10/01 12:30:00 PR Newswire
EMERYVILLE, Calif., Oct. 1, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it is currently…
   Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales  2020/09/21 12:30:00 PR Newswire
EMERYVILLE, Calif., Sept. 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that its Pipette® baby and…
   Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada  2020/09/15 12:30:00 PR Newswire
EMERYVILLE, Calif., Sept. 15, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that its Reb M natural…
   Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today  2020/09/14 11:00:00 PR Newswire
EMERYVILLE, Calif., Sept. 14, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo, President…
   The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors  2020/10/08 13:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $AMRS #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Amyris, Inc (“Amyris” or the “Company”) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On March 19, 2019, Amyris announced was unable to file its annual report for fiscal year ended December 31, 2018 on time due to “the significant time and resources that were devoted to
   Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed  2020/10/01 12:30:00 PR Newswire
EMERYVILLE, Calif., Oct. 1, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it is currently…
   Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales  2020/09/21 12:30:00 PR Newswire
EMERYVILLE, Calif., Sept. 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that its Pipette® baby and…
   Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada  2020/09/15 12:30:00 PR Newswire
EMERYVILLE, Calif., Sept. 15, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that its Reb M natural…
   Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today  2020/09/14 11:00:00 PR Newswire
EMERYVILLE, Calif., Sept. 14, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo, President…
   Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020  2020/09/08 12:30:00 PR Newswire
EMERYVILLE, Calif., Sept. 8, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo, President and…
   Amyris Scales First Fermentation-Based Cannabinoid  2020/09/01 12:30:00 PR Newswire
EMERYVILLE, Calif., Sept. 1, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has successfully…
   INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS  2020/07/29 16:25:00 Benzinga
NEW YORK , July 29, 2020 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Amyris, Inc. ("Amyris" or the "Company") (Nasdaq: AMRS) relating to the Company's June 1 and June 4, 2020 financing transactions, which permit Foris Ventures, LLC to obtain Amyris common stock. Under the terms of the transaction, Amyris shareholders would receive $3.00 for each share of Amyris common stock owned. … Full story available on Benzinga.com
   SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.  2020/07/29 01:07:00 PR Newswire
NEW YORK, July 28, 2020 /PRNewswire/ -- URGENT: SHAREHOLDER VOTE AUGUST 14, 2020 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Amyris, Inc. ("AMRS" or the "Company") (NASDAQ: AMRS) in connection with the…
   Amyris partners with IDRI to create adjuvants for COVID-19 vaccine (NASDAQ:AMRS)  2020/07/27 16:16:31 Seeking Alpha
Amyris (AMRS +4.7%) and Infectious Disease Research Institute (IDRI) has signed a binding term for a planned COVID-19 RNA (ribonucleic acid) vaccine techno

 関連キーワード  (化学_特殊化学製品 米国株 アミリス AMRS Amyris Inc.)

化学産業により作られた製品は、経済の基盤を成し自動車や電機産業のほか、日用雑貨や医薬品など生活の隅々で使用されている。化学産業は経済活動の影響を受ける面が大きく、関連株も景気動向に左右される。化学産業の基礎資材は石油から作られ原油価格の影響も受けやすい。また、日本の化学産業はアジアなど海外企業との競争も激しくなっている。

 twitter  (公式ツイッターやCEOツイッターなど)